Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1070358 | 0.85 | THRB (0.61) | THRBTSHRALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL9056866 | 0.84 | THRB (0.43) | THRBTSHRALDH1A1HSD17B10 | |
| SCHEMBL481223 | 0.82 | TSHR (0.41) | THRBTSHRALDH1A1EGLN1HSD17B10 | |
| SCHEMBL111960 | 0.82 | THRB (0.68) | THRBTSHRALDH1A1HSD17B10SMN1; SMN2 | |
| SCHEMBL262250 | 0.82 | EGLN1 (0.50) | THRBTSHRALDH1A1EGLN1HSD17B10 | |
| SCHEMBL27109623 | 0.82 | TSHR (0.51) | THRBTSHREPHX2 | |
| SCHEMBL27109620 | 0.82 | TSHR (0.51) | THRBTSHREPHX2 | |
| SCHEMBL27109614 | 0.82 | TSHR (0.51) | THRBTSHREPHX2 | |
| SCHEMBL6855594 | 0.81 | MEN1 (0.41) | THRBTSHRALDH1A1HSD17B10ALOX15 | |
| SCHEMBL9480340 | 0.81 | THRB (0.66) | THRBTSHRALDH1A1HSD17B10SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11833233-B2 | Alkali-swellable multi-functional rheology modifiers | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2023-12-05 | — | — | US | disclosed |
| EP-1331494-A1 | COMPOSITION FOR OPTICAL MATERIAL, OPTICAL MATERIAL, AND PLASTIC LENS | NOF CORPORATION (JP) | 2003-07-30 | — | — | EP | disclosed |
| US-4463149-A | UNSATURATED POLYSILOXANES | POLYMER TECHNOLOGY CORPORATION (US) | 1984-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11833233-B2 | Alkali-swellable multi-functional rheology modifiers | PUF60, CUTA, SMURF1 | THRB 4692/4885TSHR 4052/4885ALDH1A1 3385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.